Counts describe records matching each organism's published query, including trials of multi-ingredient products; they are not a count of trials of this product.
Context
Where this score sits
This formulation scores above 21.1% of the 4,101 scored formulations in this release. The score is a preference-dependent summary of the axes, not a health claim.
Evidence queries are incomplete. A2 uses the known matching records as a lower bound.
Scored using the available matching evidence. Identity: A commercial strain code is printed. Quantity disclosure: 100.0%. Potency: Potency is stated at manufacture.
Axes 3–4
Measurement and brand panel
Not a measurement product, so this axis does not apply.
No brand review panel is published in this release.
Price column
Observed price
undefined: no permitted price observation in this release
Sensitivity
Preference-dependent summary
Preference interval 57.11–62.40; rank uncertainty 1405.00–2946.00; rank class 3.
Versions
Typed label snapshot edges
No typed edge in this release.
Preference tool
Weights slider
The readout recomputes the arithmetic summary from the published component JSON. Axis fields remain primary.
femMED Probiotic: 1 of 1 selected label snapshots have a numeric Gut Index Score; GIS 61.03 on the 100-point scale; rank class 3 of 4 across 3,279 scored formulations; nominal weights varied from 80.0% to 120.0% in preference sensitivity. Window: NIH DSLD snapshot Sep 2026.
femMED Probiotic: 0 of 1 observed versions have numeric prices; latest price No numeric price observation is available in this release.. Window: NIH DSLD snapshot Sep 2026.